AC Immune (ACIU) Treasury Shares (2020 - 2025)

AC Immune (ACIU) has 6 years of Treasury Shares data on file, last reported at -$272755.0 in Q4 2025.

• Quarterly Treasury Shares fell 9.61% year-over-year to -$272755.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$272755.0 (down 9.61% YoY) and the FY2025 annual result came in at -$262936.0, down 5.66% from the prior year.
• Treasury Shares steadied at -$272755.0 in Q4 2025 per ACIU's latest filing, from -$272523.9 in the prior quarter.
• Across five years, Treasury Shares topped out at $1131.6 billion in Q4 2023 and bottomed at $939.2 billion in Q4 2024.
• The 3-year median for Treasury Shares is $955.7 billion (2025), against an average of $1008.8 billion.
• The widest annual swing landed in 2021, when Treasury Shares plunged 124215.44%; it then jumped 100.1% in 2022.
• Tracing ACIU's Treasury Shares over 5 years: stood at -$134.5 million in 2021, then jumped by 100.1% to $128714.7 in 2022, then sank by 92064.79% to -$118.4 million in 2023, then jumped by 99.79% to -$248851.8 in 2024, then slipped by 9.61% to -$272755.0 in 2025.
• Per Business Quant, the three latest ACIU Treasury Shares figures stand at -$272755.0 (Q4 2025), -$272523.9 (Q3 2025), and -$263320.1 (Q2 2025).

Peer Comparison